Subscribe to Cardiovascular
View Sample

FREE Email Newsletter

VasoStitch Completes Successful In Vivo Study of Its Breakthrough Access-and-Closure System for Nonsurgical Deployment of Transcatheter Therapies

January 24, 2012 4:41 am | News | Comments

DANVILLE, Calif.--(BUSINESS WIRE)--VasoStitch, a start-up medical technology company, announced today that it has successfully completed its first in vivo study of its percutaneous access-and-closure system for the nonsurgical deployment of large-diameter transcatheter therapeutic devices...

CardioComm Solutions, Inc. Receives FDA Clearance to Market First Over-the-Counter Heart Monitoring Solution

January 23, 2012 5:44 am | News | Comments

TORONTO--(BUSINESS WIRE)--CardioComm Solutions, Inc., a global medical provider of ECG acquisition and management software solutions, received clearance from the Food and Drug Administration (FDA) for over-the-counter (OTC) sales and marketing of their consumer-based...

Precision Pulmonary Diagnostics to Offer OSA Portable Monitor Testing

January 23, 2012 5:42 am | News | Comments

HOUSTON--(BUSINESS WIRE)--Precision Pulmonary Diagnostics (PPD®) recently added portable monitor testing to its diagnostic offerings of sleep apnea in commercial drivers. PPD is an industry leader, providing turn-key sleep apnea disease management program and lab network.


Acacia Subsidiary Acquires Patents for Catheter Ablation Technology

January 23, 2012 5:37 am | News | Comments

NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Acacia Research Corporation announced today that a subsidiary has acquired patents relating to catheter ablation technology. “Acacia continues to increase the number of patent portfolios we control in the medical technology sector,” commented Paul Ryan...

Nanomedical Global Sales to Reach $130.9 Billion in 2016

January 23, 2012 5:24 am | News | Comments

Wellesley, Mass. – According to a new technical market research report, NANOTECHNOLOGY IN MEDICAL APPLICATIONS: THE GLOBAL MARKET (HLC069B) from BCC Research, nanomedical global sales totaled $72.8 billion in 2011 and are expected to increase...

Crux Biomedical's IVC Filter Receives CE Mark Approval

January 23, 2012 5:05 am | News | Comments

MENLO PARK, Calif. /PRNewswire/ -- Crux Biomedical announced it has received CE mark approval for their revolutionary inferior vena cava filter (IVCF) with bi-directional retrieval (BDR). Vena cava filters are designed to trap blood clots that can lead to a potentially fatal pulmonary embolism (PE). 

Saint Thomas Heart Opens New Ventricular Assist Device Center; One of Only 33 Dedicated Centers in United States

January 20, 2012 5:23 am | News | Comments

NASHVILLE, Tenn.--(BUSINESS WIRE)--Saint Thomas Hospital, a member of Saint Thomas Health and a national leader in cardiac care, announced today the opening of the Saint Thomas Heart Ventricular Assist Device (VAD) Center at an invitation only event at LP Field.

Covidien Provides Update on Voluntary Recall of BIS Bilateral Sensors

January 20, 2012 5:10 am | News | Comments

BOULDER, Colo.--(BUSINESS WIRE)--On November 8, 2011, Covidien initiated a voluntary recall of certain lots of its BISâ„¢ Bilateral Sensors, due to a modification which inadvertently reversed the reference and left eye electrode. This modification could potentially cause a change...


European Coronary Stent Market to Decline to $490 Million by 2016, Despite Growth in Number of Procedures

January 20, 2012 5:06 am | News | Comments

TORONTO--(BUSINESS WIRE)--According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, while the number of coronary stenting procedures performed will show steady growth, stent selling prices will decline significantly...

Gore Receives First FDA Approval for Endovascular Repair of Traumatic Aortic Transections

January 20, 2012 5:01 am | News | Comments

FLAGSTAFF, Ariz.--(BUSINESS WIRE)--W. L. Gore & Associates, Inc. (Gore) announced that the US Food and Drug Administration (FDA) has approved the Conformable GORE® TAG® Thoracic Endoprosthesis for endovascular repair of isolated lesions of the descending thoracic aorta...

Indiana's medical device industry is fifth largest in U.S. generating $10 billion annually

January 20, 2012 4:41 am | News | Comments

INDIANAPOLIS, Ind., - According to a report released today by BioCrossroads, the medical devices industry is one of Indiana's most valuable economic assets employing over 20,000 people, and generating more than $10 billion of annual economic output. The first of its kind report...

Independent Data Safety Monitoring Board Recommends St. Jude Medical's FAME II Clinical Trial Stop Enrollment Following Positive Interim Analysis

January 19, 2012 5:13 am | News | Comments

ST. PAUL, Minn.--(BUSINESS WIRE)--St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, announced today that an interim analysis of the FAME II trial has found a highly statistically significant reduction in the need for hospital readmission and urgent revascularization when...

Slovenia's 1st Total Artificial Heart Patient Discharged from UMC Ljubljana Using the Freedom Portable Driver

January 19, 2012 4:55 am | News | Comments

TUCSON, Ariz. – SynCardia Systems, Inc., manufacturer of the SynCardia temporary Total Artificial Heart, announced today that on Dec. 29, 2011, University Medical Center (UMC) Ljubljana discharged Slovenia's first Total Artificial Heart patient, 61-year-old...


Patients Report Controversial Multiple Sclerosis Treatment Improves Their Lives: Presented at ISET 2012

January 18, 2012 5:55 am | News | Comments

MIAMI BEACH, Fla.--(BUSINESS WIRE)--Although using angioplasty to treat multiple sclerosis (MS) is highly controversial, sufferers often insist it helps – in some cases dramatically, such as allowing them to walk without a cane. Patients with less severe MS also reported additional quality...

US BioDesign Launches Cardiovascular Biomaterials Business Segment

January 18, 2012 5:26 am | News | Comments

PERKASIE, Pa.--(BUSINESS WIRE)--US BioDesign announced today the launch of its cardiovascular biomaterials business segment. This portion of US BioDesign will be responsible for the research, analysis and production of products and services in the cardiovascular device area.

Medtronic Endurant II AAA Stent Graft System Launches Internationally with CE Mark

January 18, 2012 4:46 am | News | Comments

MINNEAPOLIS –– Medtronic Inc. today announced the CE (Conformité Européenne) mark and international launch of the Endurant® II AAA Stent Graft System, which meaningfully expands the options physicians outside the United States have to treat patients with abdominal aortic aneurysms...

Study Finds Intraosseous Infusion is Equivalent to Intravenous Infusion During Therapeutic Hypothermia

January 17, 2012 4:51 am | News | Comments

SAN ANTONIO--(BUSINESS WIRE)--The results of a study conducted by Vidacare Corporation comparing whether Intraosseous (IO) vascular access may be used to infuse chilled saline as effectively as peripheral intravenous (IV) access to achieve therapeutic hypothermia found no statistical...

Saudi Arabia Uses ZOLL's Temperature Management Solution to Revive Pilgrims from Heat Stroke During the Hajj Pilgrimage

January 16, 2012 5:34 am | News | Comments

CHELMSFORD, Mass.--(BUSINESS WIRE)--ZOLL® Medical Corporation, a manufacturer of medical devices and related software solutions, announced today that the Saudi Arabia Ministry of Health purchased six ZOLL intravascular temperature management (IVTM™) systems...

Humedica Releases Cutting-Edge Predictive Model to Help Prevent Congestive Heart Failure Hospitalizations

January 16, 2012 5:15 am | News | Comments

BOSTON--(BUSINESS WIRE)--Humedica, the leading clinical analytics company, today announced the launch of a new predictive analytic model that will identify patients at high-risk for a Congestive Heart Failure (CHF) hospitalization. Designed to enable providers to identify high-risk CHF patients...

Data from St. Jude Medical's ASSERT Implantable Device Monitoring Study Published in New England Journal of Medicine

January 13, 2012 5:26 am | News | Comments

ST. PAUL, Minn.--(BUSINESS WIRE)--St. Jude Medical, a global medical device company, today announced the publication of results from the ASSERT cohort study in the New England Journal of Medicine (NEJM). The ASSERT study, or ASymptomatic AF and Stroke Evaluation...

Endosense Launches TactiCath 75 Force-Sensing Catheter, Announces New Results of EFFICAS I Clinical Study

January 13, 2012 5:14 am | News | Comments

GENEVA--(BUSINESS WIRE)--Endosense, a pioneer and leader in force-sensing technology focused on improving the efficacy and safety of catheter ablation for the treatment of cardiac arrhythmias, has announced the European launch of the TactiCath 75 force-sensing ablation catheter...

Biosense Webster Completes Enrollment in Ground-Breaking SMART-AF Trial

January 13, 2012 5:05 am | News | Comments

DIAMOND BAR, Calif.--(BUSINESS WIRE)--Biosense Webster Inc., a worldwide leader in the diagnosis and treatment of cardiac arrhythmias, announced the completion of enrollment in their latest ground-breaking clinical trial, the SMART-AF Investigational Device Exemption (IDE) study.

Biosense Webster Announces FDA approval of the THERMOCOOL SF Catheter in the United States

January 13, 2012 5:03 am | News | Comments

DIAMOND BAR, Calif.--(BUSINESS WIRE)--Biosense Webster, Inc., a worldwide leader in the diagnosis and treatment of cardiac arrhythmias, announced the FDA approval of the new THERMOCOOL® SF irrigated ablation catheter in the United States. The THERMOCOOL® SF NAV Catheter...

Intellicell Biosciences announces the licensing of its proprietary patent, pending stromal vascular fraction manufacturing technology

January 11, 2012 4:52 am | News | Comments

NEW YORK--(BUSINESS WIRE)--Intellicell Biosciences, Inc., (“Intellicell”) or the (“Company”), has licensed its proprietary, patent, pending technology for the manufacture of stromal vascular fraction from adipose tissue to Cell-Innovations, Pty Limited a company headquartered...

Cameron Health Submits PMA Application to FDA for the S-ICD System

January 10, 2012 6:33 am | News | Comments

SAN CLEMENTE, Calif.--(BUSINESS WIRE)--Cameron Health, Inc. (“Cameron Health”) announced today that it has submitted the Premarket Approval (PMA) application to the Food and Drug Administration (FDA) for the S-ICD System, the world's only completely subcutaneous implantable defibrillator.

You may login with either your assigned username or your e-mail address.
The password field is case sensitive.